These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma. Gronowitz JS; Hagberg H; Källander CF; Simonsson B Br J Cancer; 1983 Apr; 47(4):487-95. PubMed ID: 6849793 [TBL] [Abstract][Full Text] [Related]
88. Intracellular lactic dehydrogenase and phosphohexose isomerase activity in leukaemia and malignant lymphoma. Ho AD; Fiehn W; Hunstein W Br J Haematol; 1982 Apr; 50(4):637-45. PubMed ID: 7066211 [TBL] [Abstract][Full Text] [Related]
89. Clinico-pathologic correlation in non-Hodgkin's lymphoma. I. Retrospective analysis using the Lukes and Collins classification. Lenner P; Lundgren E; Damber L Acta Radiol Oncol Radiat Phys Biol; 1979; 18(3):177-91. PubMed ID: 525424 [TBL] [Abstract][Full Text] [Related]
98. Elevation of serum lactic dehydrogenase levels as an early marker of occult malignant lymphoma. Rotenberg Z; Weinberger I; Fuchs Y; Erdberg A; Davidson E; Agmon J Cancer; 1984 Oct; 54(7):1379-81. PubMed ID: 6467160 [TBL] [Abstract][Full Text] [Related]
99. Extranodal lymphoma with an unusual constellation of features. McDonald CR; Paine CJ South Med J; 1975 Sep; 68(9):1177-9. PubMed ID: 1162433 [TBL] [Abstract][Full Text] [Related]
100. [Lactate dehydrogenase (LDH) in peripheral blood lymphocytes (PBL) of patients with solid tumors]. Konjević G; Jurisić V; Jakovljević B; Spuzić I Glas Srp Akad Nauka Med; 2002; (47):137-47. PubMed ID: 16078448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]